Vickie E Baracos
Vickie E Baracos is an expert in Nutrition at Cross Cancer Institute (Canada). As of September 2026, ScienceLeadR ranks Vickie E Baracos in the top 1% of experts worldwide for Cachexia, Sarcopenia and Weight Loss. Vickie E Baracos has authored 490 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 1,686 (community average: 125). How the SLR is computed.
LeadR Profile
Nutrition
Subspecialties: Oncology - Palliative Medicine - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 490
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Feeding Behaviour in the KPC Model of Pancreatic Cancer-Associated Cachexia: Alteration of Spontaneous and Evoked Feeding Behaviours. PMID 41923302 — injections, pancreatic neoplasms, disease models, animal, eating, neoplasms, food, appetite, meals, cachexia, ghrelin, sarcopenia, cancer-associated cachexia | J Cachexia Sarcopenia Muscle | 2026 | 0 |
| Multidisciplinary clinical prediction of survival of patients attending Palliative Radiation Oncology and Palliative Care clinics: a prospective cohort study. PMID 41808462 — radiation oncology, neoplasms, cohort studies, palliative care | Ann Palliat Med | 2026 | 0 |
| Harnessing lipid-driven immunometabolic pathways in omental metastases to enhance immunotherapy in patients with ovarian cancer. PMID 41775684 — cells, macrophages, stress, physiological, ovary, neoplasms, immunotherapy, neoplasm metastasis, ovarian neoplasms, signal transduction, maraviroc | Signal Transduct Target Ther Top journal | 2026 | 0 |
| Cancer Cachexia Prevalence Is Underestimated in Medical Records of Patients in a Regional Tertiary Hospital. PMID 41704163 — tertiary care centers, lung, neoplasms, lung neoplasms, prevalence, body weight, diagnosis, research, weight loss, records, cachexia, medical records, sarcopenia, cancer-associated cachexia | J Cachexia Sarcopenia Muscle | 2026 | 0 |
| Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study. PMID 41652656 — pancreatic neoplasms, stomach, neoplasms, drug therapy, signs and symptoms, enzymes, parenteral nutrition, weight loss, enzyme replacement therapy, therapeutics, prospective studies, chemotherapy | Nutr Clin Pract | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Nutritional Supplementation in Head and Neck Cancers NCT05379712 — radiotherapy, gtp-binding proteins, nutritional support, malnutrition, fatty acids, omega-3, nutrition therapy, neoplasms, drug therapy, food, energy intake, head and neck neoplasms, therapeutics, eicosapentaenoic acid, taste, fatty acids, chemotherapy | Phase 2 | Recruiting | 2024 |
LeadR Networks
Main global connection map